Global Pneumococcal Vaccine Market Growth 2025-2031

March 2025 | 82 pages | ID: G5E21419433EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Pneumococcal Vaccine market size is predicted to grow from US$ 7269 million in 2025 to US$ 7782 million in 2031; it is expected to grow at a CAGR of 1.1% from 2025 to 2031.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

LP Information, Inc. (LPI) ' newest research report, the “Pneumococcal Vaccine Industry Forecast” looks at past sales and reviews total world Pneumococcal Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pneumococcal Vaccine sales for 2025 through 2031. With Pneumococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Pneumococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumococcal Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Vaccine and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• PPSV 23
• PCV 7/13
• PCV 10

Segmentation by End User:

• Child
• Adult

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• GSK
• MSD
• Sanofipasteur
• CDIBP

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pneumococcal Vaccine market?

What factors are driving Pneumococcal Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pneumococcal Vaccine market opportunities vary by end market size?

How does Pneumococcal Vaccine break out by Type, by End User?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pneumococcal Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Pneumococcal Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Pneumococcal Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pneumococcal Vaccine Segment by Type
  2.2.1 PPSV
  2.2.2 PCV 7/13
  2.2.3 PCV
2.3 Pneumococcal Vaccine Sales by Type
  2.3.1 Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2020-2025)
2.4 Pneumococcal Vaccine Segment by End User
  2.4.1 Child
  2.4.2 Adult
2.5 Pneumococcal Vaccine Sales by End User
  2.5.1 Global Pneumococcal Vaccine Sale Market Share by End User (2020-2025)
  2.5.2 Global Pneumococcal Vaccine Revenue and Market Share by End User (2020-2025)
  2.5.3 Global Pneumococcal Vaccine Sale Price by End User (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Pneumococcal Vaccine Breakdown Data by Company
  3.1.1 Global Pneumococcal Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Pneumococcal Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global Pneumococcal Vaccine Revenue by Company (2020-2025)
  3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pneumococcal Vaccine Product Location Distribution
  3.4.2 Players Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Pneumococcal Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Pneumococcal Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Pneumococcal Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pneumococcal Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global Pneumococcal Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Pneumococcal Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pneumococcal Vaccine Sales Growth
4.4 APAC Pneumococcal Vaccine Sales Growth
4.5 Europe Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa Pneumococcal Vaccine Sales Growth

5 AMERICAS

5.1 Americas Pneumococcal Vaccine Sales by Country
  5.1.1 Americas Pneumococcal Vaccine Sales by Country (2020-2025)
  5.1.2 Americas Pneumococcal Vaccine Revenue by Country (2020-2025)
5.2 Americas Pneumococcal Vaccine Sales by Type (2020-2025)
5.3 Americas Pneumococcal Vaccine Sales by End User (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pneumococcal Vaccine Sales by Region
  6.1.1 APAC Pneumococcal Vaccine Sales by Region (2020-2025)
  6.1.2 APAC Pneumococcal Vaccine Revenue by Region (2020-2025)
6.2 APAC Pneumococcal Vaccine Sales by Type (2020-2025)
6.3 APAC Pneumococcal Vaccine Sales by End User (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pneumococcal Vaccine by Country
  7.1.1 Europe Pneumococcal Vaccine Sales by Country (2020-2025)
  7.1.2 Europe Pneumococcal Vaccine Revenue by Country (2020-2025)
7.2 Europe Pneumococcal Vaccine Sales by Type (2020-2025)
7.3 Europe Pneumococcal Vaccine Sales by End User (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pneumococcal Vaccine by Country
  8.1.1 Middle East & Africa Pneumococcal Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pneumococcal Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pneumococcal Vaccine Sales by End User (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of Pneumococcal Vaccine
10.4 Industry Chain Structure of Pneumococcal Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pneumococcal Vaccine Distributors
11.3 Pneumococcal Vaccine Customer

12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION

12.1 Global Pneumococcal Vaccine Market Size Forecast by Region
  12.1.1 Global Pneumococcal Vaccine Forecast by Region (2026-2031)
  12.1.2 Global Pneumococcal Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pneumococcal Vaccine Forecast by Type (2026-2031)
12.7 Global Pneumococcal Vaccine Forecast by End User (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Pneumococcal Vaccine Product Portfolios and Specifications
  13.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 GSK
  13.2.1 GSK Company Information
  13.2.2 GSK Pneumococcal Vaccine Product Portfolios and Specifications
  13.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GSK Main Business Overview
  13.2.5 GSK Latest Developments
13.3 MSD
  13.3.1 MSD Company Information
  13.3.2 MSD Pneumococcal Vaccine Product Portfolios and Specifications
  13.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 MSD Main Business Overview
  13.3.5 MSD Latest Developments
13.4 Sanofipasteur
  13.4.1 Sanofipasteur Company Information
  13.4.2 Sanofipasteur Pneumococcal Vaccine Product Portfolios and Specifications
  13.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Sanofipasteur Main Business Overview
  13.4.5 Sanofipasteur Latest Developments
13.5 CDIBP
  13.5.1 CDIBP Company Information
  13.5.2 CDIBP Pneumococcal Vaccine Product Portfolios and Specifications
  13.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 CDIBP Main Business Overview
  13.5.5 CDIBP Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PPSV 23
Table 4. Major Players of PCV 7/13
Table 5. Major Players of PCV 10
Table 6. Global Pneumococcal Vaccine Sales by Type (2020-2025) & (K Doses)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Table 8. Global Pneumococcal Vaccine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pneumococcal Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Pneumococcal Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Pneumococcal Vaccine Sale by End User (2020-2025) & (K Doses)
Table 12. Global Pneumococcal Vaccine Sale Market Share by End User (2020-2025)
Table 13. Global Pneumococcal Vaccine Revenue by End User (2020-2025) & ($ million)
Table 14. Global Pneumococcal Vaccine Revenue Market Share by End User (2020-2025)
Table 15. Global Pneumococcal Vaccine Sale Price by End User (2020-2025) & (USD/Dose)
Table 16. Global Pneumococcal Vaccine Sales by Company (2020-2025) & (K Doses)
Table 17. Global Pneumococcal Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Pneumococcal Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pneumococcal Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Pneumococcal Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Vaccine Products Offered
Table 23. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pneumococcal Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Pneumococcal Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pneumococcal Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pneumococcal Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pneumococcal Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Pneumococcal Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pneumococcal Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pneumococcal Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Pneumococcal Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Pneumococcal Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pneumococcal Vaccine Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Pneumococcal Vaccine Sales by End User (2020-2025) & (K Doses)
Table 39. APAC Pneumococcal Vaccine Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Pneumococcal Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pneumococcal Vaccine Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Pneumococcal Vaccine Sales by End User (2020-2025) & (K Doses)
Table 44. Europe Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Pneumococcal Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pneumococcal Vaccine Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Pneumococcal Vaccine Sales by End User (2020-2025) & (K Doses)
Table 48. Middle East & Africa Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pneumococcal Vaccine Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Pneumococcal Vaccine Sales by End User (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccine
Table 53. Key Market Challenges & Risks of Pneumococcal Vaccine
Table 54. Key Industry Trends of Pneumococcal Vaccine
Table 55. Pneumococcal Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pneumococcal Vaccine Distributors List
Table 58. Pneumococcal Vaccine Customer List
Table 59. Global Pneumococcal Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Pneumococcal Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pneumococcal Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Pneumococcal Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pneumococcal Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Pneumococcal Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pneumococcal Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Pneumococcal Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pneumococcal Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Pneumococcal Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pneumococcal Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Pneumococcal Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pneumococcal Vaccine Sales Forecast by End User (2026-2031) & (K Doses)
Table 72. Global Pneumococcal Vaccine Revenue Forecast by End User (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Pneumococcal Vaccine Product Portfolios and Specifications
Table 75. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. GSK Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Pneumococcal Vaccine Product Portfolios and Specifications
Table 80. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. MSD Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. MSD Pneumococcal Vaccine Product Portfolios and Specifications
Table 85. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. MSD Main Business
Table 87. MSD Latest Developments
Table 88. Sanofipasteur Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofipasteur Pneumococcal Vaccine Product Portfolios and Specifications
Table 90. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Sanofipasteur Main Business
Table 92. Sanofipasteur Latest Developments
Table 93. CDIBP Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CDIBP Pneumococcal Vaccine Product Portfolios and Specifications
Table 95. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. CDIBP Main Business
Table 97. CDIBP Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pneumococcal Vaccine
Figure 2. Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Pneumococcal Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pneumococcal Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pneumococcal Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pneumococcal Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of PPSV 23
Figure 12. Product Picture of PCV 7/13
Figure 13. Product Picture of PCV 10
Figure 14. Global Pneumococcal Vaccine Sales Market Share by Type in 2025
Figure 15. Global Pneumococcal Vaccine Revenue Market Share by Type (2020-2025)
Figure 16. Pneumococcal Vaccine Consumed in Child
Figure 17. Global Pneumococcal Vaccine Market: Child (2020-2025) & (K Doses)
Figure 18. Pneumococcal Vaccine Consumed in Adult
Figure 19. Global Pneumococcal Vaccine Market: Adult (2020-2025) & (K Doses)
Figure 20. Global Pneumococcal Vaccine Sale Market Share by End User (2024)
Figure 21. Global Pneumococcal Vaccine Revenue Market Share by End User in 2025
Figure 22. Pneumococcal Vaccine Sales by Company in 2025 (K Doses)
Figure 23. Global Pneumococcal Vaccine Sales Market Share by Company in 2025
Figure 24. Pneumococcal Vaccine Revenue by Company in 2025 ($ millions)
Figure 25. Global Pneumococcal Vaccine Revenue Market Share by Company in 2025
Figure 26. Global Pneumococcal Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Pneumococcal Vaccine Sales 2020-2025 (K Doses)
Figure 29. Americas Pneumococcal Vaccine Revenue 2020-2025 ($ millions)
Figure 30. APAC Pneumococcal Vaccine Sales 2020-2025 (K Doses)
Figure 31. APAC Pneumococcal Vaccine Revenue 2020-2025 ($ millions)
Figure 32. Europe Pneumococcal Vaccine Sales 2020-2025 (K Doses)
Figure 33. Europe Pneumococcal Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Pneumococcal Vaccine Sales 2020-2025 (K Doses)
Figure 35. Middle East & Africa Pneumococcal Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Americas Pneumococcal Vaccine Sales Market Share by Country in 2025
Figure 37. Americas Pneumococcal Vaccine Revenue Market Share by Country (2020-2025)
Figure 38. Americas Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Figure 39. Americas Pneumococcal Vaccine Sales Market Share by End User (2020-2025)
Figure 40. United States Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Pneumococcal Vaccine Sales Market Share by Region in 2025
Figure 45. APAC Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
Figure 46. APAC Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Figure 47. APAC Pneumococcal Vaccine Sales Market Share by End User (2020-2025)
Figure 48. China Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. India Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Pneumococcal Vaccine Sales Market Share by Country in 2025
Figure 56. Europe Pneumococcal Vaccine Revenue Market Share by Country (2020-2025)
Figure 57. Europe Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Figure 58. Europe Pneumococcal Vaccine Sales Market Share by End User (2020-2025)
Figure 59. Germany Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. France Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Pneumococcal Vaccine Sales Market Share by End User (2020-2025)
Figure 67. Egypt Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Pneumococcal Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2025
Figure 73. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 74. Industry Chain Structure of Pneumococcal Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Pneumococcal Vaccine Sales Market Forecast by Region (2026-2031)
Figure 77. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Pneumococcal Vaccine Sales Market Share Forecast by End User (2026-2031)
Figure 81. Global Pneumococcal Vaccine Revenue Market Share Forecast by End User (2026-2031)